MicrobiologybioRxivPreprint
Targeting HIV-1 with CRISPR/Cas9 delivered by retargeted adenoviruses effectively suppresses viral replication
Sarah Klinnert, Patrick C. Freitag, Andreas Plückthun, Karin Jutta Metzner
This study combines CRISPR/Cas9 with retargeted adenoviruses to suppress HIV-1 replication in primary CD4+ T cells.